Enfortumab vedotin plus pembrolizumab approved in Japan for urothelial carcinoma
Japan’s Ministry of Health, Labour, and Welfare (MHLW) has approved the combination of enfortumab vedotin-ejfv (EV, Padcev) and pembrolizumab …Read More
The Heartbeat of World events
Japan’s Ministry of Health, Labour, and Welfare (MHLW) has approved the combination of enfortumab vedotin-ejfv (EV, Padcev) and pembrolizumab …Read More
